EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as Europe Synchrony digital operating room system received U.S. FDA clearance in April and initial orders and shipments are ongoing ──────────────────────────────────────────────────────────────────────────────────────────────────── Definitive agreement to acquire Robocath creates a leading robotic platform, combining complementary technologies to deliver next-generation fully-integrated robotic solutions for the full spectrum of endovascular procedures St. Louis, MO, May 12, 2026 (Globe Newswire) - Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the first quarter ended March 31, 2026. “Stereotaxis is in one of the most exciting periods of its history. We are achieving significant regulatory approvals, executing strategic acquisitions, and witn…
Open exhibit ↗Current Report · Items 2.02, 9.01 · 8-K
Stereotaxis, Inc.
STXSNYSE_AMERICANEQUITYCurrent
Results of Operations and Financial Condition
Item Results 2.02 of Operations and Financial Condition On May 12, 2026, Stereotaxis, Inc. (the “Company”) issued a press release (the “Earnings Press Release”) setting forth its financial results for the 2026 first quarter. A copy of the Earnings Press Release is being filed as Exhibit 99.1 hereto, and the statements contained therein are incorporated by reference herein.
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item Results
2.02 of Operations and Financial Condition
On
May 12, 2026, Stereotaxis, Inc. (the “Company”) issued a press release (the “Earnings Press Release”) setting
forth its financial results for the 2026 first quarter. A copy of the Earnings Press Release is being filed as Exhibit 99.1 hereto, and
the statements contained therein are incorporated by reference herein.